【ChiCTR1800019706】Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial
ChiCTR1800019706
尚未开始
/
/
/
2018-11-24
/
/
兒童哮喘
Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial
Effects of a Multimedia Educational Programme for Children with Asthma or Recurrent Wheeze: A Randomized Controlled Trial
1. To determine the effectiveness of the multimedia education programme on improving asthma childrens health outcomes; 2. To determine the effectiveness of the multimedia education programme on enhancing parents KAP on asthma.
随机平行对照
卫生服务研究
The potential participants will be randomly allocated to either the intervention or control group in equal probability to reduce the bias on this new method of intervention. Group assignments will be placed in sealed, opaque and identical envelopes at a randomised order to maintain the allocation concealment.
Single blind
NA
/
56
/
2018-12-01
2019-09-30
/
Children: 1. A child between 4–11 years old; 2.A child admitted for asthma (ICD-10) or recurrent wheezing (more than two episodes in the last year) regardless if the diagnosis is initial or recurrent. Parent: 1. Parent with a child between 4 and 11 years old who is admitted for asthma or wheezing attack during the study period.;
请登录查看Children: 1. Chronic lung disease, such as bronchopulmonary dysplasia, which will confound the lung function assessment; 2. Developmental delay; 3. Cannot communicate in Cantonese and understand Chinese; 4. Participation in similar study; This study will exclude children aged 0 to 3 years old because making a certain diagnosis of asthma is difficult for young children given that wheezing or cough symptoms are common even for those who do not have asthma (Pedersen et al., 2011). Furthermore, adolescents (aged 12 to 17 years old) pose significant differences in cognitive ability compared with young children. They will have different delivery approaches to health education. Thus, children aged 12 to 17 years old will also be excluded from this study to decrease the confounding variables including level of anxiety, asthma control or medication adherence. Parent: 1. Cannot communicate in Cantonese and understand Chinese; 2. Has no smartphone; 3. Participation in similar study.;
请登录查看基督教聯合醫院
/
基督教聯合醫院的其他临床试验
香港基督教聯合醫院的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 60
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

